biomedicina slovenica


"HALOPERIDOL" : 36

  1. Bogićević Sanja; Živin Marko
    Efficacy of potential atypical antipsychotic lek-8829 on behavioral effects in rat model of catalepsy and inhibition of amphetamine induced psychomotor stimulation
    [[Učinkovitost potencialnega atipičnega antipsihotika lek-8829 na vedenjske učinke na podganjih modelih katalepsije ter z amfetaminom povzročene psihomotorične stimulacije]]
    2015
  2. Treuer Tamás; Bartiene R.; Blinc-Pesek Marjeta; Molnar B.; Pecenak J.
    An observational study (IC-SOHO) comparing olanzapine, risperidone, quetiapine, and haloperidol in the treatment of patients with schizophrenia
    2004
  3. Giegling Ina; Drago Antonio; Dolžan Vita; Kores-Plesničar Blanka; Schaefer Martin; Hartmann Annette M; Sander Thomas; Toliat Mohammad Reza; Moeller Hans-Juergen; Stassen Hans H
    Glutamatergic gene variants impact the clinical profile of efficacy and side effects of haloperidol
    2011
  4. Dolžan Vita; Serretti Alessandro; Mandelli Laura; Koprivšek Jure; Kastelic Matej; Kores-Plesničar Blanka
    Acute antipyschotic efficacy and side effects in schizophrenia: association with serotonin transporter promoter genotypes
    2008
  5. Lopuh Mateja
    Uporaba lidokaina, ketamina in haloperidola v podkožni infuziji za zdravljenje nevropatske bolečine
    [Use of lidocaine, ketamine and haloperidol in a subcutaneous infusion for treatment of neuropathic pain]
    2008
  6. Dolžan Vita; Kores-Plesničar Blanka; Serretti Alessandro; Mandelli Laura; Zalar bojan; Koprivšek Jure; Breskvar Katja
    Polymorphisms in dopamine receptor DRD1 and DRD2 genes and psychopathological and extrapyramidal symptoms in patients on long-term antipsychotic treatment
    2007
  7. Lopuh Mateja
    Akutna ekstrapiramidna simtomatika po enkratnem odmerku haloperidola v podkožni infuziji: prikaz primera
    2007
  8. Kores-Plesničar Blanka; Zalar Bojan; Breskvar Katja; Dolžan Vita
    The influence of the CYP2D6 polymorphism on psychopathological and extrapyramidal symptoms in the patients on long-term antipsychotic treatment
    2006
  9. Glavan G; Živin M
    Differential expression of striatal synaptotagmin mRNA isoforms in hemiparkinsonian rats
    2005
  10. Yang Shi-Bing; Major Felix; Tietze Lutz F; Rupnik Marjan
    Block of delayed-rectifier potassium channels by reduced haloperidol and related compounds in mouse cortical neurons
    2005
  11. Yang Shi-Bing; Proks Peter; Ashcroft Frances M; Rupnik Marjan
    Inhibition of ATP-sensitive potassium channels by haloperidol
    2004
  12. Potočnik-Dajčman Nataša; Gregorič-Kumperščak Hojka
    Uporaba netipičnih antipsihotikov v razvojnem obdobju
    [Atypical antipsychotic use in children and adolescents]
    2002
  13. Živin Marko; Šprah Lilijana; Sket Dušan
    Preizkus delovanja ergolinskega derivata Lek-9928 kot delnega agonista na dopaminskih receptorjih
    1994
  14. Petty Richard G
    Neurological comlications of treatment with antipsychotic agents
    2002
  15. Bitter Istvan
    Acute treatment strategies: new options
    2002
  16. Currier Glenn
    Approaches for treating psychotic agitation
    2002
  17. Krčevski-Škvarč N
    Sedation of agitated critically ill patient without an artificial airway
    2000
  18. Bartolo-Abela Marcelle
    Hypnotherapy for Tourette's syndome: evidence for its effectiveness, and treatment protocols for use, in familial and non-familial cases
    2000
  19. Kores-Plesničar Blanka; Zalar Bojan
    Nevropsihološke spremembe pri zgodnji fazi shizofrenije med 12-mesečnim zdravljenjem z olanzapinom, risperidonom ali haloperidolom: slovenski komentar
    2000
  20. Purdon Scot E; Jones Barry D W; Stip Emanuel; Labelle Alan; Addington Don; David Stacy R; Breier Alan; Tollefson Gary D
    Nevropsihološke spremembe pri zgodnji fazi shizofrenije med 12-mesečnim zdravljenjem z olanzapinom, risperidonom ali haloperidolom
    [Neuropsychological change in early phase schizophrenia during 12 months of treatment with olanzapine, risperdol, or haloperidol]
    2000
  21. Folnegović-Šmalc Vera
    Farmakoterapija shizofrenije
    2000
  22. Šprah Lilijana
    Učinek spojine LEK-8829 na dopaminskih receptorjih pri podgani z enostransko okvaro striatuma
    1999
  23. Grobovšek-Opara Sonja
    Vpliv zdravil na tveganje zbolevanja za jetrno cirozo
    [Impact of drugs on the morbidity risk of liver cirrhosis]
    1999
  24. Šprah Lilijana; Živin Marko; Sket Dušan
    Ergoline derivative LEK-8829-inducet turning behavior in rats with unilateral striatal ibotenic acid lesions: interaction with bromocriptine
    1999
  25. Živin Marko; Šprah Lilijana; Sket Dušan
    Antiparkinsonian potential of interaction of LEK-8829 with bromocriptine
    1998
  26. Kores-Plesničar Blanka
    Utjecaj neuroleptične terapije na spolne funkcije muškaraca
    1995
  27. Dossenbach Martin
    Olanzapine: An exciting atypical antipsychotic - the clinical experience
    1997
  28. Šprah Lilijana
    Dopaminergična aktivnost ergolinskega derivata LEK-8829
    1997
  29. Živin M; Šprah L; Sket D
    The D1 receptor-mediated effects of the ergoline derivative LEK-8829 in rats with unilateral 6-hydroxydopamine lesions
    1996
  30. Krisch I
    Vrednotenje antipsihotičnega potenciala dveh novosintetiziranih derivatov ergolina pri poskusnih živalih
    1995
  31. Kogoj A
    Delirij
    [Delirium]
    1994
  32. Brecelj-Kobe M
    Nevroleptično zdravljenje pri otrocih
    1996
  33. Krisch I; Bole-Vunduk B; Lavrič B; Ocvirk A; Pepelnak M; Budihna MV; Sket D
    Pharmacological studies with two new ergoline derivatives, the potential antipsychotics LEK-8829 and LEK-8841
    1994
  34. Macedoni-Lukšič M
    Amfetaminski model psihoze pri podganah: modulacija dopaminskega sistema s holinergičnimi
    1993
  35. Jakupi M; Dreshaj IA; Mandura I; Haxhiu MA
    Efekat etanola na tonus izolovanog glatkog mišića plućne arterije
    [Effect of ethanol on the isolated smooth muscle of pulmonary artery]
    1991
  36. Stracenski B
    Utjecaj doze haloperidola na motilnost probavnog trakta
    1989



New search      Comments      Top of page Institute for Biostatistics and Medical Informatics